North American Schizophrenia Drugs Market Research and Forecast 2020-2026


Posted September 22, 2020 by globalomr

North American Schizophrenia Drugs Market Size, Share & Trends Analysis Report by Therapeutic Class (Second-Generation Antipsychotics, Third-Generation Antipsychotics, and Others) and by Treatment (Oral and Injectables) and Forecast 2020-2026

 
North American schizophrenia drugs market is projected to grow at a significant CAGR of 2.1% during the forecast period (2020-2026). The increasing incidence of anxiety disorders in North America is generating the demand for different types of medication and therapies for its treatment and thereby is expected to propel the growth of the schizophrenia drugs market in the region. The incorporation of anti-stress programs including yoga, therapy, Employee Assistance Program (EAPs), social activities, childcare initiatives, provision of work from home, flexible timings, and mindfulness training are some other factors that can make a significant contribution to the schizophrenia drugs market growth in the region.

A full report of North American Schizophrenia Drugs Market is available at: https://www.omrglobal.com/industry-reports/north-american-schizophrenia-drugs-market

In addition to the rising prevalence of major depressive disorders and anxiety disorders, the high prevalence of PTSD in the US is further supporting the growth of the schizophrenia drugs market. The National Centre for PTSD offers mobile applications (apps) including self-help, companion apps, and other apps. The different self-help apps for monitoring of PTSD include PTSD Family Coach, Mindfulness Coach, VetChange, and AIMS. The treatment companion apps offered by the National Centre for PTSD, for use with a health care provider to make treatment easier include CPT Coach, PE Coach, CBT-iCoach, ACT Coach, and Stagecoach. Other apps for monitoring of related disorders include Mood Coach, Concussion Coach, Parenting2Go, Moving Forward, and Stay Quit Coach. These apps work on both the iOS and Android devices. In addition, the National Centre for PTSD offers online programs including PTSD coach online, VetChange, community reinforcement and family training-post trauma stress disorder (CRAFT-PTSD), community reinforcement and family training-substance use disorder (CRAFT-SUD).

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-schizophrenia-drugs-market

Market Coverage

• The market number available for – 2019-2026
• Base year- 2019
• Forecast period- 2020-2026
• Segments Covered
o By Therapeutic Class
o By Treatment
• Countries Covered
o US
o Canada
• Allergan PLC, Catalent, Inc., Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc.

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/north-american-schizophrenia-drugs-market

North American Schizophrenia Drugs Market – Segmentation

By Therapeutic Class

• Second Generation Antipsychotics
• Third Generation Antipsychotics
• Others (First Generation Antipsychotics)

By Treatment

• Oral
• Injectables

North American Schizophrenia Drugs Market – Segmentation by Geography

• United States
• Canada

Company Profiles

• Alkermes PLC
• Allergan PLC
• AstraZeneca PLC
• Biogen Inc.
• Catalent, Inc.
• Eli Lilly and Co.
• H. Lundbeck A/S
• Indivior PLC
• Johnson & Johnson Services, Inc.
• Lupin Ltd.
• Merck & Co., Inc.
• Minerva Neurosciences, Inc.
• Otsuka Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Sunovion Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Arti Sharma
Phone +91 780-304-0404
Business Address 305-308, Commerce House, Janjeerwala Square, Indore, Madhya Pradesh 452001
Country India
Categories Business , Health , Medical
Tags Health , medical , Pharmaceuticals , healthcare
Last Updated September 22, 2020